GlassScriptPhysician profile
David A Sipala
NPI 1821351263
$93,666.81
in general payments reported to CMS, 2019-2025
33 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,811 · 2020: $1,093 · 2021: $5,125 · 2022: $1,839 · 2023: $28K · 2024: $42K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $19K · Food and Beverage: $6,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,315.00 |
| Travel and Lodging | $19,112.63 |
| Food and Beverage | $6,371.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $80,232.16 | 2019-2025 | Prostep, Ortholoc 2 Lapifuse, Prostep Mica |
| Arthrex, INC. | $2,792.68 | 2021 | |
| Wright Medical Technology, INC. | $1,707.17 | 2019-2020 | |
| Smith+Nephew, INC. | $1,340.42 | 2019-2025 | Stravix, Evos Mini, Iodosorb Ointment 40g USA |
| Kairos Surgical INC | $1,215.80 | 2021 | |
| Medartis INC. | $863.74 | 2019-2020 | |
| Integra Lifesciences Corporation | $688.94 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $634.06 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $412.49 | 2019-2020 | |
| Trilliant Surgical LLC. | $408.74 | 2019 | |
| Horizon Therapeutics Plc | $402.29 | 2019-2021 | |
| Bone Support INC. | $325.68 | 2020-2025 | Cerament G, Ceramentbone Void Filler |
| Acumed LLC | $292.50 | 2020-2024 | Acumed |
| Celularity INC. | $278.00 | 2019 | |
| Mimedx Group, INC. | $270.27 | 2024-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $207.75 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $197.92 | 2019-2023 | Tapestry |
| Djo, LLC | $193.23 | 2025 | Cmf |
| Orthofix Medical, INC. | $188.96 | 2019-2024 | Physio-Stim |
| Treace Medical Concepts, INC. | $180.47 | 2019 | |
| Depuy Synthes Sales INC. | $158.81 | 2024-2025 | Healix Knotless Peek, Orthocord, Dynacord |
| Bioventus LLC | $140.93 | 2022-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $97.66 | 2023 | Additive Orthopedics |
| Flower Orthopedics Coporation | $85.26 | 2025 | |
| Ossio INC | $66.12 | 2021 | |
| Kerecis Limited | $66.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $64.04 | 2025 | |
| Access Pro Medical, LLC | $40.23 | 2025 | Matriderm |
| Misonix INC | $30.89 | 2019-2021 | |
| Polynovo North America LLC | $27.41 | 2025 | Novosorb Btm |
| Convatec INC. | $19.86 | 2025 | |
| Medtronic, INC. | $19.30 | 2025 | Intellis Adaptivestim |
| Alfasigma USA, INC. | $16.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sipala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.